Wolff Stefani

EVP and COO at NRIX; Chief Development Officer at Principia Biopharma Inc.

Sold, on record
$883k
Dollars the filings state
Form 4 sales
8
Latest May 1, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Principia Biopharma Inc.Plan not stated
    Dec 16 2019

    Sold 5,505 shares at $49.43 ($272k)

    Wolff Stefani, Chief Development Officer

    Sold 13.4% of holdings ($2M position)35,609 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Principia Biopharma Inc.Plan not stated
    Mar 16 +91 days

    Sold 5,504 shares at $46.16 ($254k)

    Wolff Stefani, Chief Development Officer

    Sold 13.4% of holdings ($1.9M position)35,609 shares leftFiling

  3. 3 Form 4 sale Principia Biopharma Inc.Plan not stated
    Jun 15 +91 days

    Sold 5,504 shares at $60.75 ($334k)

    Wolff Stefani, Chief Development Officer

    Sold 22.4% of holdings ($1.5M position)19,096 shares leftFiling

  4. 4 Form 4 sale NRIXUnusual
    May 2 +686 days

    Sold 330 shares at $11.75 ($4k)

    Wolff Stefani, EVP and COO

    Sold 34.3% of holdings ($11k position)632 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale NRIXPlan not stated
    Aug 1 +91 days

    Sold 356 shares at $15.67 ($6k)

    Wolff Stefani, EVP and COO

    Sold 22.3% of holdings ($25k position)1,238 shares leftFiling

  6. 6 Form 4 sale NRIXPlan not stated
    Oct 31 +91 days

    Sold 350 shares at $12.88 ($5k)

    Wolff Stefani, EVP and COO

    Sold 9.3% of holdings ($48k position)3,402 shares leftFiling

  7. 7 Form 4 sale NRIXPlan not stated
    Jan 30 +91 days

    Sold 424 shares at $11.78 ($5k)

    Wolff Stefani, EVP and COO

    Sold 9.7% of holdings ($51k position)3,940 shares left1.2x usual sizeFiling

  8. 8 Form 4 sale NRIXNo plan
    May 1 +91 days

    Sold 342 shares at $9.88 ($3k)

    Wolff Stefani, EVP and COO

    No 10b5-1 planSold 5.3% of holdings ($64k position)6,113 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Wolff Stefani
Source
May 1, 2023NRIXEVP and COOForm 4 sale342$3k5.3%No planSEC
Jan 30, 2023NRIXEVP and COOForm 4 sale424$5k9.7%Plan not statedSEC
Oct 31, 2022NRIXEVP and COOForm 4 sale350$5k9.3%Plan not statedSEC
Aug 1, 2022NRIXEVP and COOForm 4 sale356$6k22.3%Plan not statedSEC
May 2, 2022NRIXEVP and COOForm 4 sale330$4k34.3%UnusualSEC
Jun 15, 2020Principia Biopharma Inc.Chief Development OfficerForm 4 sale5,504$334k22.4%Plan not statedSEC
Mar 16, 2020Principia Biopharma Inc.Chief Development OfficerForm 4 sale5,504$254k13.4%Plan not statedSEC
Dec 16, 2019Principia Biopharma Inc.Chief Development OfficerForm 4 sale5,505$272k13.4%Plan not statedSEC